2-Arylmethyl-1, 4-benzoquinones. II. Novel Inhibitors of Platelet Aggregation : Synthesis and Pharmacological Evaluation

Two new series of 2-arylmethyl-1, 4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective effect against endothelial cell injury. Structure-activity re...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 45; no. 4; pp. 668 - 674
Main Authors SUZUKI, Kenji, TATSUOKA, Toshio, ISHIHARA, Takafumi, OGINO, Ryoko, MIYAZAKI, Tomoko, SATOH, Fumio, MIYANO, Seiji, SUMOTO, Kunihiro
Format Journal Article
LanguageEnglish
Published Tokyo The Pharmaceutical Society of Japan 1997
Maruzen
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Two new series of 2-arylmethyl-1, 4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective effect against endothelial cell injury. Structure-activity relationship studies indicated that 2b, 2d and 3b are potent inhibitors of platelet aggregation induced by arachidonic acid (AA) with an IC50 in the range of 1-10 μg/ml. Among them, 3b showed a significant inhibitory activity against endothelial cell injury caused by hydrogen peroxide (H2O2) at 1 μM.
AbstractList Two new series of 2-arylmethyl-1,4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective against endothelial cell injury. Structure-activity relationship studies indicated that 2b, 2d and 3b are potent inhibitors of platelet aggregation induced by arachidonic acid (AA) with an IC50 in the range of 1-10 micrograms/ml. Among them, 3b showed a significant inhibitory activity against endothelial cell injury caused by hydrogen peroxide (H2O2) at 1 microM.
Two new series of 2-arylmethyl-1, 4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed significant inhibition of platelet aggregation and some of them possessed a protective effect against endothelial cell injury. Structure-activity relationship studies indicated that 2b, 2d and 3b are potent inhibitors of platelet aggregation induced by arachidonic acid (AA) with an IC50 in the range of 1-10 μg/ml. Among them, 3b showed a significant inhibitory activity against endothelial cell injury caused by hydrogen peroxide (H2O2) at 1 μM.
Author MIYAZAKI, Tomoko
MIYANO, Seiji
SUZUKI, Kenji
SATOH, Fumio
SUMOTO, Kunihiro
OGINO, Ryoko
TATSUOKA, Toshio
ISHIHARA, Takafumi
Author_xml – sequence: 1
  fullname: SUZUKI, Kenji
– sequence: 2
  fullname: TATSUOKA, Toshio
– sequence: 3
  fullname: ISHIHARA, Takafumi
– sequence: 4
  fullname: OGINO, Ryoko
– sequence: 5
  fullname: MIYAZAKI, Tomoko
– sequence: 6
  fullname: SATOH, Fumio
– sequence: 7
  fullname: MIYANO, Seiji
– sequence: 8
  fullname: SUMOTO, Kunihiro
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2676116$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9145502$$D View this record in MEDLINE/PubMed
BookMark eNpFkM9v0zAUxy00NLrBhTuSD4gDIsG_E-9WVduoNMEk4Bw5zkvqyXGKnU6Uvx6XVuXy3uH70fvqfa7QRZgCIPSWkpIyUX-227YUslSqfoEWlIuqkIzxC7QghOiCccVfoauUnghhklT8El1qKqQkbIF-s2IZ936EebP3Bf2ERdFC-DP92rlDSSrxel3ir9MzeLwOG9e6eYoJTz1-9GYGDzNeDkOEwcxuCvgGf9-HeQPJJWxChx83Jo7GTn4anDUe3z4bv_uHvkYve-MTvDnta_Tz7vbH6kvx8O1-vVo-FFbUui6YNr1lRvWi5ZL10EktlFS6FZwJJjRIVStR0661lTGyo4xw0G3f5bhTIPk1-nC8u435KUhzM7pkwXsTYNqlptLZimZ1Bj8eQRunlCL0zTa60cR9Q0lz0NxkzY2QTdac4Xenq7t2hO6Mnrzm_P0pNyn_3UcTrEtnjKlKUaoytjpiT2k2A5xzE2dnPRwaqZb1oVUcRy7_n2a5DQT-F32Qnm0
CODEN CPBTAL
CitedBy_id crossref_primary_10_1016_j_bmcl_2006_03_074
crossref_primary_10_1002_chin_199743096
ContentType Journal Article
Copyright The Pharmaceutical Society of Japan
1997 INIST-CNRS
Copyright_xml – notice: The Pharmaceutical Society of Japan
– notice: 1997 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1248/cpb.45.668
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-5223
EndPage 674
ExternalDocumentID 10_1248_cpb_45_668
9145502
2676116
article_cpb1958_45_4_45_4_668_article_char_en
Genre Journal Article
GroupedDBID ---
.55
2WC
53G
5GY
6J9
AAUGY
ABTAH
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
GX1
HH5
JSF
JSH
KQ8
L7B
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7M
ZGI
ZY4
.GJ
29B
3O-
AABQG
ABFLS
ADGIM
BKOMP
E3Z
IQODW
JMI
MOJWN
X7J
XSB
ZE2
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4898-29afc2a6f4b352fed5946569b4324249e5686481dbc7aa5d1203e9bfd324d6e53
ISSN 0009-2363
IngestDate Fri Aug 16 00:45:02 EDT 2024
Fri Aug 23 01:31:04 EDT 2024
Sat Sep 28 08:33:28 EDT 2024
Fri Nov 25 16:31:38 EST 2022
Thu Aug 17 20:25:56 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Endothelial cell
Enzyme
Quinone
Enzyme inhibitor
Rabbit
Anticoagulant
Lagomorpha
Oxygen heterocycle
Morpholine derivatives
In vitro
Antiplatelet agent
L-Lactate dehydrogenase
Vertebrata
Mammalia
Cytoprotector
Structure activity relation
Animal
Bicyclic compound
Carboxamide
Benzenic compound
Aromatic compound
Oxidoreductases
Benzofuran derivatives
Chemical synthesis
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4898-29afc2a6f4b352fed5946569b4324249e5686481dbc7aa5d1203e9bfd324d6e53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/cpb1958/45/4/45_4_668/_article/-char/en
PMID 9145502
PQID 79002928
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_79002928
crossref_primary_10_1248_cpb_45_668
pubmed_primary_9145502
pascalfrancis_primary_2676116
jstage_primary_article_cpb1958_45_4_45_4_668_article_char_en
PublicationCentury 1900
PublicationDate 1997-00-00
PublicationDateYYYYMMDD 1997-01-01
PublicationDate_xml – year: 1997
  text: 1997-00-00
PublicationDecade 1990
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Chemical & pharmaceutical bulletin
PublicationTitleAlternate Chem. Pharm. Bull.
PublicationYear 1997
Publisher The Pharmaceutical Society of Japan
Maruzen
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: Maruzen
References 5) Goto G., Okamoto K., Okutani T., Imada I., Chem. Pharm. Bull., 33, 4422 (1985).
9) a) Abe M., Morita I., Murota S., PG LT Essent. Fatty Acids, 34, 69 (1988
2) Hamberg M., Svensson J., Samuelsson B., Proc. Natl. Acad. Sci. U.S.A., 72, 2994 (1975).
6) Smith W.E., J. Org. Chem., 37, 3972 (1972).
3) Shiraishi M., Kato K., Terao S., Ashida Y., Terashita Z., Kito G., J. Med. Chem., 32, 2214 (1989).
4) Syper L., Kloc K., Mlochowski J., Szulc Z., Synthesis, 1979, 521.
1) Suzuki K., Tatsuoka T., Murakami T., Ishihara T., Aisaka K., Inoue T., Ogino R., Kuroki M., Miyazaki T., Satoh F., Miyano S., Sumoto K., Chem. Pharm. Bull., 44, 139 (1996).
7) Johnson R.A., Nidy E.G., Aiken J.W., Crittenden N.J., Gorman R.R., J. Med. Chem., 29, 1461 (1986).
b) Whorton A.R., Montogomery M.E., Kent R.S., J. Clin. Invest., 76, 295 (1985).
8) Born G.V.R., Nature (London), 194, 927 (1962).
References_xml
SSID ssj0025073
Score 1.5411773
Snippet Two new series of 2-arylmethyl-1, 4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed...
Two new series of 2-arylmethyl-1,4-benzoquinones (2 and 3) were synthesized for evaluation of their pharmacological activities. These compounds showed...
SourceID proquest
crossref
pubmed
pascalfrancis
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 668
SubjectTerms 1, 4-benzoquinone
Animals
anti-platelet aggregation
arachidonic acid
Arachidonic Acid - pharmacology
Benzoquinones - chemistry
Benzoquinones - pharmacology
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
endothelial cell
Endothelium, Vascular - drug effects
Endothelium, Vascular - metabolism
hydrogen peroxide
Hydrogen Peroxide - metabolism
Male
Medical sciences
Pharmacology. Drug treatments
Platelet Aggregation - drug effects
Platelet Aggregation Inhibitors - chemical synthesis
Rabbits
Structure-Activity Relationship
Title 2-Arylmethyl-1, 4-benzoquinones. II. Novel Inhibitors of Platelet Aggregation : Synthesis and Pharmacological Evaluation
URI https://www.jstage.jst.go.jp/article/cpb1958/45/4/45_4_668/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/9145502
https://search.proquest.com/docview/79002928
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Chemical and Pharmaceutical Bulletin, 1997/04/15, Vol.45(4), pp.668-674
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVg8ICEEF8TBQaWQHtpUxrXcRLEyzRtWmF0Q0qlvkV2YndlU1st6aT213NvnCbNAPHxYlWObTk5pzfXse-5hLx3mUgDg9nLEtc43E-kI02QODphYDGV7qcBRiN_HYqTEf889sb1gcwiuiRX3WT9y7iS_0EV6gBXjJL9B2SrQaECfgO-UALCUP4Vxsw5uF5dYRLo1ZUDJumQO0rP1mDrpzPU4O-2B4Nuezi_0aiscTFV0yK3zrxIHp3DCydvywksuCfVEY9sNQOPEEVKCgGBWte6wLKWBt_2aSvNAWRR2WXzjVxtq3sXe0_r5WUzAXYk82w5v5SNE9uD7GKKUtKNyrPJtEgUXh5yTMvgPb9heUOH9UtjVlpeKyRZMoxvmVFhU-2Ub2Rh8_j8ZOwZxwCGZKG63OtWXbYVtYdn8fHo9DSOjsbRXXKPgTHCY59fvlU7TeAB-lW2PZxfKWELY3-oR244Lfe_g9-OggwPFzKDR2lsBpTfL1EKVyV6TB6Vawx6YAnzhNzRs6dk_9wis-rQqI65yzp0n57XMK-ekZsmqzq3OUWBU7TgFK05ReeGbjhFtzj1kVaMosAoeotRtGbUczI6PooOT5wyO4eT8CDE0B1pEiaF4QqceKNTL0TtvVChxiMs6rUnAsFhOaQSX0ovdVmvr0NlUricCu31d8kOzvsFoT1wSo2ngDAoHKJV4GnusyDp9YwwieAt8m7z-OOFFWGJcfEKIMUAUsy9GEBqkU8WmapN-cfENqiphO24LaB5fRXuHKxJi-w18KxGYcIXrita5O0G3xhMMO6ryZmeL7PYD3Fvm8EEdi3sVdewSAPAXv6x6yvywOoi47e912Qnv17qPfB2c_WmoOsPFHCyGw
link.rule.ids 315,783,787,4031,27935,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2-Arylmethyl-1%2C4-benzoquinones.+II.+Novel+inhibitors+of+platelet+aggregation%3A+synthesis+and+pharmacological+evaluation&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=Suzuki%2C+K&rft.au=Tatsuoka%2C+T&rft.au=Ishihara%2C+T&rft.au=Ogino%2C+R&rft.date=1997&rft.issn=0009-2363&rft.volume=45&rft.issue=4&rft.spage=668&rft.epage=674&rft_id=info:doi/10.1248%2Fcpb.45.668&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon